Assess whether RWE can replace or only supplement an RCT (d600d7)

Situation

In a 505(b)(2) program relying on literature plus a bridging study, scientific-advice briefing book is the evidence after a literature paper the 505(b)(2) package leans on getting retracted. Labeling negotiator has to pick RWE can replace or Only supplement an RCT for this Pharma & Life Sciences CMC and Development Pathways close using scientific-advice briefing book.

Decision

Labeling negotiator in a 505(b)(2) program relying on literature plus a bridging study must choose RWE can replace / Only supplement an RCT using scientific-advice briefing book after a literature paper the 505(b)(2) package leans on getting retracted.

Hypotheses to test

• Labeling negotiator can defend RWE can replace from scientific-advice briefing book after a literature paper the 505(b)(2) package leans on getting retracted in a Pharma & Life Sciences challenge.
• Labeling negotiator cannot defend RWE can replace from scientific-advice briefing book; Only supplement an RCT is what the extract actually supports after a literature paper the 505(b)(2) package leans on getting retracted.
• A literature paper the 505(b)(2) package leans on getting retracted never reached the population in scientific-advice briefing book — reopen intake, do not close RWE can replace or.
• Two facts in scientific-advice briefing book after a literature paper the 505(b)(2) package leans on getting retracted conflict for labeling negotiator; hold this CMC and Development Pathways file.

Analysis required

• Test a protocol deviation versus a safety signal versus a filing gap on RWE can replace or.
• Check whether scientific-advice briefing book supports the labeled claim labeling negotiator would keep.
• Map FDA-response timing and owner in a 505(b)(2) program relying on literature plus a bridging study.
• For this Pharma & Life Sciences CMC and Development Pathways file, read scientific-advice briefing book against a literature paper the 505(b)(2) package leans on getting retracted and write the one fact that would move RWE can replace or for labeling negotiator.

Recommendation

Choose RWE can replace / Only supplement an RCT on this Pharma & Life Sciences / CMC and Development Pathways packet (scientific-advice briefing book after a literature paper the 505(b)(2) package leans on getting retracted). Lead with the Pharma & Life Sciences option scientific-advice briefing book can support after a literature paper the 505(b)(2) package leans on getting retracted, then the two facts that force it, then the Monday action for labeling negotiator in a 505(b)(2) program relying on literature plus a bridging study.